Abstract
Rectus sheath hematoma is a collection of blood in the sheath of rectus abdominis muscle due to an injury of one of the epigastric vessels or the muscle itself. It is a rare condition that could be caused by the use of anticoagulant injections. We report a 60-year-old lady who received enoxaparin injection on the lower abdomen. Subsequently, she developed bladder perforation secondary to rectus sheath hematoma and was diagnosed using CT angiography scan. Exploratory laparotomy was performed and bleeding was controlled with bladder wall repair. Patient developed multi-organ failure. Three days later, the patient died. Rectus sheath hematoma is a rare condition and it is often associated with the use of anticoagulant injection. Healthcare providers should be aware of such complication for prevention and early diagnosis.
Rectus sheath hematoma (RSH) is a collection of the blood in the rectus abdominis muscle sheath due to injury of one of the epigastric vessels or the muscle itself.1 Rectus sheath hematoma has many causes but commonly caused by trauma, abdominal surgeries, subcutaneous drugs injection, hematological diseases, hypertension, pregnancy, and physical activity. However, it rarely happens spontaneously.1,2 It is a rare condition that has been reported to occur with anticoagulant injection.3-5 Rectus sheath hematoma can mimic other acute abdominal conditions, early recognition of such cases can save a patient’s life. The aim of this paper is to draw the attention of the healthcare providers regarding this condition to minimize its occurrence and improve early diagnosis.
Case Report
Patient information
A 60-year-old lady was presented to the emergency department with 2 attacks of syncope. She was known to have hypertension, atrial fibrillation, and ischemic heart disease. Four years earlier, she underwent percutaneous mitral balloon valvuloplasty in Yemen. She was on warfarin, furosemide, and bisoprolol. She had not consulted any cardiologist since her last intervention.
Clinical findings
Upon assessment, she was asymptomatic. Examination revealed hemodynamic stability with basal lung crepitation only. Her body mass index was 18.9.
Diagnostic assessment
Laboratory workup revealed hemoglobin 106 g/L and international normalized ratio was 1.39. Other laboratory workups were normal. Computed tomography scan of the brain showed multiple low attenuation areas in the right occipital lobe and right basal ganglia, suggestive of acute brain ischemic insult. Echocardiogram revealed severe mitral stenosis with severe biatrial enlargement, moderate tricuspid regurgitation, and moderate pulmonary hypertension. She was diagnosed with severe mitral valve stenosis and acute stroke. She was admitted for further management and workup.
Therapeutic intervention
She was assessed by a cardiac surgeon who recommended mitral valve replacement. Warfarin was stopped and replaced with enoxaparin. On day 12 post admission, she was injected with enoxaparin (Clexane®) on her lower abdomen. Few hours later, she started to develop lower abdominal pain with lower abdominal tenderness. A Foley catheter was inserted and drained concentrated urine. Over the next 6 hours from injection, the pain increased and she started to develop lower abdominal swelling. Her blood pressure became 73/56 mm Hg and pulse rate, 116 beats/min. Laboratory workup revealed hemoglobin drop from 98 to 85 g/L, creatinine level increase from 103 to 158 mmol/L, and lactic acid level 9.5 mmol/L. Working diagnosis was ischemic bowel, perforated viscus, or abdominal bleeding. The patient and family refused surgery. She was resuscitated and transferred to the intensive care unit. She became stable after resuscitation. Computed tomography angiography result showed large retroperitoneal hematoma with active bleeding and intact major vessels (Figures 1-3).
Coronal CT scan of abdomen and pelvis large retroperitoneal hematoma (arrow) with area of active bleeding (circle).
Axial CT scan of abdomen shows large retroperitoneal hematoma with area of active bleeding (circle).
Sagittal CT scan of abdomen and pelvis shows large retroperitoneal hematoma with hyperdense area (circle). Foley catheter inside the bladder (yellow arrow).
Ten to 12 hours post injection, the Foley catheter suddenly started to drain a large amount of fresh blood and her condition deteriorated rapidly. Transfusion of large amounts of blood products was carried out. A high dosage of inotrope support was started. She was brought to the operating room. Exploratory laparotomy showed large retroperitoneal hematoma with bleeding from the rectus sheath. In addition, there was perforation in the upper part of the posterior bladder wall. There was no other source of bleeding other than the one from the rectus sheath, which was controlled. Bladder wall was repaired.
Follow up and outcomes
She was transferred back to the ICU. She developed multi-organ failure.Three days postoperatively, she coded and died (Table 1).
Discussion
Rectus abdominis muscle is supplied by the superior epigastric artery (SEA) and the inferior epigastric artery (IEA). Rectus sheath hematoma is commonly from IEA injury due to 2 reasons. First, the location of IEA at the perforating muscle branches. Second, absence of posterior rectus sheath below the arcuate line. These known facts explains why RSH is more common in the lower abdomen and more prone to pelvic extension.6 Rectus sheath hematoma with anticoagulant injection is frequently reported worldwide. Most of the reported cases occurred in patients who are female, elderly and having low BMI.4,5
Bladder perforation secondary to space occupying pelvic collection is rarely reported.7,8 Multiple studies have shown that low BMI, female gender and advanced age are risk factors for bladder perforation during endoscopic bladder tumor resection. This has been attributed to thin wall thickness of the bladder in these patients.9,10
Patient perspective
Our patient was elderly, female, and with low BMI. These are considered risk factors for RSH and thin bladder wall.
The sequence of events started from enoxaparin injection, which led to vascular injury. The bleeding was retroperitoneal which created a tamponade because of the limited space. This contributed to the stability of the patient initially. As the hematoma became larger, the bladder wall was stretched over the Foley catheter which caused perforation of the bladder. The hematoma was drained through the catheter and lost its tamponade effect. This contributed to the rapid hemodynamic deterioration of the patient. This complication could be prevented if high risk patients are injected in different location. Patient who have low BMI, female gender, and elderly should be injected with enoxaparin in the upper part of the abdomen instead of the lower abdomen.
The aim of this case report was to emphasize 2 facts. First, simple procedures if not carried out properly can lead to drastic events. Second, hematoma is the result of injury to the epigastric vessels and not due to potentiated drug effect as stated in some reports.
In conclusion, a healthcare provider administering subcutaneous anticoagulant should be aware of such complications. Prevention can be achieved through good training and knowledge of the basic anatomy to avoid vessel or muscle injury. Rectus sheath hematoma should be suspected in the differential diagnosis of any patient complaining of abdominal pain post subcutaneous lower abdominal injection.
Withdrawal policy
By submission, the author grants the journal right of first publication. Therefore, the journal discourages unethical withdrawal of manuscript from the publication process after peer review. The corresponding author should send a formal request signed by all co-authors stating the reason for withdrawing the manuscript. Withdrawal of manuscript is only considered valid when the editor accepts, or approves the reason to withdraw the manuscript from publication. Subsequently, the author must receive a confirmation from the editorial office. Only at that stage, authors are free to submit the manuscript elsewhere.
No response from the authors to all journal communication after review and acceptance is also considered unethical withdrawal. Withdrawn manuscripts noted to have already been submitted or published in another journal will be subjected to sanctions in accordance with the journal policy. The journal will take disciplinary measures for unacceptable withdrawal of manuscripts. An embargo of 5 years will be enforced for the author and their co-authors, and their institute will be notified of this action.
Acknowledgment
The authors would like to thank Dr. Mohamed S. Elsharkawy, Radiologist, for his contribution of reviewing CT scan images.
Footnotes
Disclosure. Authors have no conflict of interests, and the work was not supported or funded by any drug company.
- Received October 25, 2017.
- Accepted December 25, 2017.
- Copyright: © Saudi Medical Journal
This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.